2008. ISPOR European Congress – The Contribution of the Measurement of Treatment Acceptability to Understand Patients’ Adherence to Long-Term Treatments. Results from a Feasability Study Conducted with In Fine Pharma®: A Community-Pharmacy Network Dedicated to Pharmacoepidemiological Surveys

Saussier C, Van Ganse E, Augé-Caumon MJ, Chamba G, Marrel A, Benmedjahed K, Longin J. The Contribution of the Measurement of Treatment Acceptability to Understand Patients’ Adherence to Long-Term Treatments. Results from a Feasability Study Conducted with In Fine Pharma®: A Community-Pharmacy Network Dedicated to Pharmacoepidemiological Surveys. Value Health. 2008 Nov;11(6):A409. Presented at: ISPOR 11th Annual European Congress; November 9, 2008; Athens, Greece.